"Breakthrough Pill for Menopause: Preventing Brittle Bones and Weight Gain"

A new drug, P7C3, originally studied for neurological diseases, has shown promise in preventing menopause-related bone loss and weight gain. The drug protected bones in models with low estrogen, reduced inflammation, and prevented over-activity of bone-absorbing cells. It also prevented weight gain and increased beneficial gut bacteria activity. Additionally, P7C3 has shown potential in protecting bones from radiation therapy damage and inhibiting certain cancer cell growth. Future studies will explore its potential for treating osteoporosis and long-term effects.